GETINGE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 183.2 SEK | -2.89% |
|
-2.50% | -18.30% |
| May. 15 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
| May. 15 | Getinge Shares Sink After It Limits Sales of Heart Devices | DJ |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -18.30% | 4.88B | B | ||
| +75.69% | 12.57B | B- | ||
| +8.29% | 6.66B | C- | ||
| +15.10% | 5.5B | D+ | ||
| +14.96% | 4.1B | - | ||
| -20.83% | 3.89B | B- | ||
| -27.53% | 2.83B | C | ||
| +44.04% | 2.31B | C- | ||
| +1.98% | 2.07B | - | ||
| +9.75% | 1.97B | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- GETI B Stock
- Ratings Getinge AB
